此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Assessment of Executive Functions After Covid-19

2021年11月2日 更新者:Mehmet Diyaddin Güleken、Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital

May Covid-19 Impair Executive Functions? A Crossectional Study

As it is evident that Covid-19 may have some impacts on cognition, the primary aim of this study is to investigate -if any- deficits of attention, working memory and executive functions after Covid-19.

研究概览

地位

完全的

详细说明

Since Covid-19 (Coronavirus Disease-2019) was declared as a pandemic by the World Health Organization (WHO) on December 31, 2019, it is still widespread and deadly. As an ongoing pandemic, it has led to a panic and then a controlled fear in societies. In many studies, neuropsychological deficits were observed in Covid-19 patients both during the illness and after recovery. A recent study found that impairment in cognitive functions continued after recovery of Covid-19, and it was associated with peripherical inflammatory markers, such as C-Reactive Protein (CRP). CRP, as a peripherical inflammatory marker, has been proven to be inversely related to serum levels of the brain-derived neurotrophic factor (BDNF), an important neurotrophin in the growth and differentiation of neurons. In this study, attention, working memory and executive functions of Covid-19 patients at post-covid period and its relation with the severity of the disease will be investigated.

研究类型

观察性的

注册 (实际的)

128

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习地点

      • Diyarbakır、火鸡、21070
        • Sağlık Bilimleri Üniversitesi Gazi Yaşargil Training and Research Hospital

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

18年 及以上 (成人、年长者)

接受健康志愿者

是的

有资格学习的性别

全部

取样方法

概率样本

研究人群

In this study, 50 healthcare personnel diagnosed as Covid-19 by RT-PCR treated at the Department of Infectious Diseases, Gazi Yaşargil Tranining and Research Hospital, Sağlık Bilimleri Üniversitesi, Diyarbakır, have been randomly recorded and followed up for 60 days, and age, sex, education level and professionally matched 50 healthy subjects randomly recruited from the personnel of the same hospital.

描述

Inclusion Criteria:

Covid-19 patients:

  • Diagnosed as Covid-19 by RT-PCR at least 60 days but not more than 90 days ago
  • Asymptomatic at the moment
  • Not having any other general medical, neurological or psychiatric conditions except Covid-19 at the time of acute infection

Healthy subjects:

  • Not having any of Covid-19 symptoms at the testing time point
  • Not having any general medical, neurological or psychiatric condition

Exclusion Criteria:

Covid-19 patients:

  • Diagnosed as Covid-19 by RT-PCR less than 60 days or more than 90 days ago
  • Having any symptom of acute phase of Covid-19
  • Having any other general medical, neurlogical or psychiatric contidions

Healthy subjects:

  • Having any of Covid-19 symptoms at the testing time point
  • Having any general medical, neurological or psychiatric condition

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

队列和干预

团体/队列
Patients
Subjects who have been Covid positive by RT-PCR at least 60 days ago and not having any symptoms of Covid-19 at the moment
Healthy
Subjects who do not have any general medical, neurological or psychiatric disorder

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Neuropsychological test scores
大体时间:Up to 90 days
Neuropsychological test scores of Covid-19 patients in comparison with healthy control subjects
Up to 90 days

次要结果测量

结果测量
措施说明
大体时间
Severity of the disease
大体时间:Up to 90 days
Neuropsychological test score changes according to the disease severity of Covid-19 patients
Up to 90 days

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

调查人员

  • 首席研究员:Mehmet D Güleken, MD、Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital

出版物和有用的链接

负责输入研究信息的人员自愿提供这些出版物。这些可能与研究有关。

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2020年10月30日

初级完成 (实际的)

2021年4月30日

研究完成 (实际的)

2021年11月1日

研究注册日期

首次提交

2021年2月22日

首先提交符合 QC 标准的

2021年2月24日

首次发布 (实际的)

2021年2月25日

研究记录更新

最后更新发布 (实际的)

2021年11月9日

上次提交的符合 QC 标准的更新

2021年11月2日

最后验证

2021年11月1日

更多信息

与本研究相关的术语

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)?

不

IPD 计划说明

All the data of the participants is being declared as it will be preserved, in the informed consent at the point of enrollment

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅